Brief: Theseus Pharmaceuticals Reports Q1 2023 Financial Results, Business Highlights
11/05/2023 13:31
May 11 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS ANNOUNCES BUSINESS HIGHLIGHTS AND
REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
* $243.6 MILLION OF CASH, CASH EQUIVALENTS, MARKETABLE
SECURITIES
AS OF MARCH 31, WITH RUNWAY PROJECTED INTO Q3 2025
* Q1 EARNINGS PER SHARE VIEW $-0.42 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPnbdTd1va
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7